This study is to investigate the quality of life of 93 patients with advanced lung cancer.
对93例晚期肺癌患者生活质量进行了调查。
Materials and Methods BAI and BAE were performed in 350 patients with advanced lung cancer.
资料与方法采用支气管动脉灌注、栓塞治疗中晚期肺癌350例，其中发生高位截瘫3例0。
Conclusion Reasonable use of MPA can improve the life quality of patients with advanced lung cancer treated with chemotherapy.
结论甲孕酮如能正确合理地用于晚期癌症的治疗，可以全面改善化疗期间癌症患者的生活质量。
Objective To further study the remission rate and the remission time of the patients with advanced lung cancer treated by selective bronchial arterial infusion.
目的探讨选择性支气管动脉灌注化疗对肺癌治疗的缓解率和缓解时间。
Injective emulsion can relieve pain and improve life quality of patients with lung cancer in advanced stage.
结论康莱特注射乳剂，能缓解疼痛症状，改善晚期癌症患者的生活质量。
Objective it is to discuss the clinical significance of Kanglaite injection combined with chemotherapy on life quality improved in non-small cell lung cancer (NSCLC) patients in advanced stage.
目的探讨康莱特注射液联合化疗对晚期非小细胞肺癌(NSCLC)患者生活质量改善的临床意义。
The patients with locally advanced lung cancer had remarkable impairment of immune function, which mainly behaved stronger immunosuppression.
中晚期肺癌患者免疫功能存在明显障碍，主要表现为机体免疫抑制作用的增强。
Conclusion Extended resection of the heart, great vessels or both can remarkably increase the long term survival and improve the prognosis in patients with locally advanced lung cancer.
结论肺切除合并受肺癌侵犯的心脏大血管切除重建术能明显提高患者的生存率，改善患者预后。
Objective: To investigate the efficacy and safety of docetaxel administrated weekly plus carboplatin in the treatment of patients with advanced non-small-cell lung cancer (NSCLC).
目的：探讨多西他赛(艾素)每周给药联合卡铂治疗晚期非小细胞肺癌的临床疗效和不良反应。
Objective to observe the efficacy and toxicity of gemcitabine of different dosages and methods plus carboplatin in patients with advanced non-small-cell lung cancer (NSCLC).
目的观察不同剂量、用法的吉西他滨联合伯尔定治疗晚期非小细胞肺癌的疗效和不良反应。
Objective To evaluate therapeutic effect and adverse reaction of pamidronate(Bonin) Combined with chemotherapy in patients of bone metastases of advanced lung cancer.
目的观察帕米磷酸二钠（博宁）联合化疗对肺癌骨转移的疗效及不良反应。
Method: 30 patients with advanced non small cell lung cancer (NSCLC) were treated by Paclitaxel combined chemotherapy, which at least each of given 2 cycles.
方法：对30例晚期非小细胞肺癌患者采用含泰素联合化疗，每例至少化疗2周期。
Methods Lobectomy or pneumonectomy combined with resection of part of the left atrium were carried out in 34 patients with locally advanced lung cancer.
方法对34例局部晚期肺癌患者施行了肺切除加左心房部分切除术。
Objective To study the effect of selective bronchial artery infusion (BAI) and chemotherapy in the treatment of patients with intermediate and advanced lung cancer.
目的探讨支气管动脉灌注化疗(BAI)对中晚期肺癌的疗效及影响因素。
Objective To observe the recent effect of combination chemotherapy with topotecan(TPT) and cisplatin(PDD) in the treatment of patients with advanced non_small cell lung cancer.
目的观察拓扑替康联合顺铂治疗晚期非小细胞肺癌的近期疗效。
Conclusion: Elemene emulsion combined with chemotherapy may make the life quality become better and increase the treatment effects of patients with advanced non-small cell lung cancer.
目的：观察榄香烯乳剂联合化疗治疗晚期非小细胞肺癌的疗效与安全性。
Objective To support a reasonable and standard TCM treatment principle for advanced non-small-cell lung cancer (NSCLC) by exploring TCM syndrome features in NSCLC patients with factor analysis.
目的采用因子分析的方法，探讨晚期非小细胞肺癌（NSCLC）中医临床证候特征，为中医药合理规范化地参与晚期肺癌的治疗提供思路。
Objective:Local regional relapse is one of the most important factors which result in death for patients with local advanced non small cell lung cancer (NSCLC).
研究目的：局部进展期非小细胞肺癌，局部控制失败是死亡的重要原因，如果能在不增加治疗毒副作用前提下，提高局部控制率必然会提高疗效。
Objective To evaluate the efficacy and safety of gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC).
目的观察吉非替尼单药治疗对晚期非小细胞肺癌 （NSCLC）老年患者的效果和安全性。
Objective To investigate the efficacy and safety of domestic docetaxel plus cisplatin regimen in patients with advanced non-small-cell lung cancer (NSCLC).
目的评价国产多西紫杉醇治疗晚期非小细胞肺癌的临床疗效和安全性。
The patients with advanced stage of non-small cell lung cancer in non-smoking male patients are more than those in smoking male patients.
非吸烟男性患者非小细胞肺癌晚期病例较吸烟男性患者多。
Conclusion For elderly patients with advanced non-small cell lung cancer and COPD, the use of erlotinib might achieve better security and effectiveness.
结论厄洛替尼单药对晚期非小细胞肺癌合并COPD的患者不良反应小，耐受性好，疗效可接受。
Objective To assess the survival rate and life quality of patients with intermediate and advanced non-small cell lung cancer (NSCLC) after argon-helium cryoablation.
目的评价氩氦刀靶向治疗中晚期非小细胞肺癌的生存率和生活质量。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
To evaluate the clinical efficacy and the security of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer and COPD.
评价单药厄洛替尼治疗晚期非小细胞肺癌合并COPD患者的疗效和安全性。
应用推荐